137 related articles for article (PubMed ID: 33836412)
1. Ground-glass hepatocellular inclusions are associated with polypharmacy.
Lu HC; González IA; Byrnes K
Ann Diagn Pathol; 2021 Jun; 52():151740. PubMed ID: 33836412
[TBL] [Abstract][Full Text] [Related]
2. Ground-glass, polyglucosan-like hepatocellular inclusions: A "new" diagnostic entity.
Lefkowitch JH; Lobritto SJ; Brown RS; Emond JC; Schilsky ML; Rosenthal LA; George DM; Cairo MS
Gastroenterology; 2006 Sep; 131(3):713-8. PubMed ID: 16952540
[TBL] [Abstract][Full Text] [Related]
3. Liver glycogen bodies: ground-glass hepatocytes in transplanted patients.
Bejarano PA; Garcia MT; Rodriguez MM; Ruiz P; Tzakis AG
Virchows Arch; 2006 Nov; 449(5):539-45. PubMed ID: 17024424
[TBL] [Abstract][Full Text] [Related]
4. Ground Glass-Like Inclusions: Associated with Liver Toxicity.
Deniz K
Turk Patoloji Derg; 2021; 37(1):51-55. PubMed ID: 33021734
[TBL] [Abstract][Full Text] [Related]
5. Hepatic disease associated with ground-glass inclusions in hepatocytes after cyanamide therapy.
Bruguera M; Lamar C; Bernet M; Rodés J
Arch Pathol Lab Med; 1986 Oct; 110(10):906-10. PubMed ID: 3021086
[TBL] [Abstract][Full Text] [Related]
6. Glycogen pseudoground glass change in hepatocytes.
Wisell J; Boitnott J; Haas M; Anders RA; Hart J; Lewis JT; Abraham SC; Torbenson M
Am J Surg Pathol; 2006 Sep; 30(9):1085-90. PubMed ID: 16931952
[TBL] [Abstract][Full Text] [Related]
7. Lafora-like ground-glass inclusions in hepatocytes of pediatric patients: a report of two cases.
O'Shea AM; Wilson GJ; Ling SC; Minassian BA; Turnbull J; Cutz E
Pediatr Dev Pathol; 2007; 10(5):351-7. PubMed ID: 17929993
[TBL] [Abstract][Full Text] [Related]
8. Use of a monoclonal antibody against Lafora bodies for the immunocytochemical study of ground-glass inclusions in hepatocytes due to cyanamide.
Hashimoto K; Hoshii Y; Takahashi M; Mitsuno S; Hanai N; Watanabe Y; Ishihara T
Histopathology; 2001 Jul; 39(1):60-5. PubMed ID: 11454045
[TBL] [Abstract][Full Text] [Related]
9. Adult polyglucosan body disease: a rare presentation with chronic liver disease and ground-glass hepatocellular inclusions.
Hajdu CH; Lefkowitch JH
Semin Liver Dis; 2011 May; 31(2):223-9. PubMed ID: 21538287
[TBL] [Abstract][Full Text] [Related]
10. Ground-glass hepatocytes in fibrinogen storage disease in Japanese Black calves.
Yamada M; Nakamura K; Nakajima Y; Yamamoto M; Komae H; Okuda K; Tsuji M; Arai M
J Comp Pathol; 2002; 126(2-3):95-9. PubMed ID: 11944997
[TBL] [Abstract][Full Text] [Related]
11. Cyanamide-associated alcoholic liver disease: a sequential histological evaluation.
Yokoyama A; Sato S; Maruyama K; Nakano M; Takahashi H; Okuyama K; Takagi S; Takagi T; Yokoyama T; Hayashida M
Alcohol Clin Exp Res; 1995 Oct; 19(5):1307-11. PubMed ID: 8561306
[TBL] [Abstract][Full Text] [Related]
12. Cyanamide-induced liver dysfunction after abstinence in alcoholics: a long-term follow-up study on four cases.
Suzuki Y; Yokoyama A; Nakano M; Okuyama K; Takahashi H; Tamai H; Maruyama K; Ishii H
Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):100S-105S. PubMed ID: 10803790
[TBL] [Abstract][Full Text] [Related]
13. Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B.
Mathai AM; Alexander J; Kuo FY; Torbenson M; Swanson PE; Yeh MM
Hum Pathol; 2013 Aug; 44(8):1665-71. PubMed ID: 23574780
[TBL] [Abstract][Full Text] [Related]
14. Pale bodies in hepatocellular carcinoma.
Moon WS; Yu HC; Chung MJ; Kang MJ; Lee DG
J Korean Med Sci; 2000 Oct; 15(5):516-20. PubMed ID: 11068987
[TBL] [Abstract][Full Text] [Related]
15. Cyanamide-induced liver injury. A predictable lesion.
Vazquez JJ; Guillen FJ; Zozaya J; Lahoz M
Liver; 1983 Aug; 3(4):225-30. PubMed ID: 6323909
[TBL] [Abstract][Full Text] [Related]
16. Ground-glass hepatocytes: light and electron microscopy. Characterization of the different types.
Vázquez JJ
Histol Histopathol; 1990 Jul; 5(3):379-86. PubMed ID: 1966881
[TBL] [Abstract][Full Text] [Related]
17. Ground glasslike hepatocytes produced by glycogen-membrane complexes ("glycogen bodies").
Wills EJ
Ultrastruct Pathol; 1992; 16(4):491-503. PubMed ID: 1323894
[TBL] [Abstract][Full Text] [Related]
18. Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: a heuristically highly relevant phenotype.
Bannasch P
World J Gastroenterol; 2012 Dec; 18(46):6701-8. PubMed ID: 23239906
[TBL] [Abstract][Full Text] [Related]
19. Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma.
Tsai HW; Lin YJ; Wu HC; Chang TT; Wu IC; Cheng PN; Yen CJ; Chan SH; Huang W; Su IJ
Oncotarget; 2016 May; 7(19):27724-34. PubMed ID: 27027237
[TBL] [Abstract][Full Text] [Related]
20. Ground-glass-like hepatocellular inclusions in the course of adult-onset Still's disease.
Sari A; Tunakan M; Ozmen M; Turkkan E
Mod Rheumatol; 2010 Feb; 20(1):90-2. PubMed ID: 19802652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
